Ingalls & Snyder LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Sell |
4,650
-1,662
| -26% | -$130K | 0.01% | 325 |
|
|
2025
Q1 | $457K | Sell |
6,312
-412
| -6% | -$29.8K | 0.02% | 293 |
|
|
2024
Q4 | $498K | Sell |
6,724
-3,463
| -34% | -$256K | 0.02% | 284 |
|
|
2024
Q3 | $672K | Sell |
10,187
-72
| -0.7% | -$4.75K | 0.03% | 261 |
|
|
2024
Q2 | $948K | Sell |
10,259
-250
| -2% | -$23.1K | 0.04% | 221 |
|
|
2024
Q1 | $1M | Sell |
10,509
-114
| -1% | -$10.9K | 0.04% | 214 |
|
|
2023
Q4 | $810K | Sell |
10,623
-1,090
| -9% | -$83.1K | 0.04% | 227 |
|
|
2023
Q3 | $811K | Buy |
11,713
+975
| +9% | +$67.5K | 0.04% | 224 |
|
|
2023
Q2 | $1.01M | Buy |
+10,738
| New | +$1.01M | 0.05% | 207 |
|